108 related articles for article (PubMed ID: 19265263)
1. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells.
Mori K; Fujimoto-Ouchi K; Onuma E; Noguchi M; Shimonaka Y; Yasuno H; Nishimura T
Biomed Res; 2009 Feb; 30(1):47-51. PubMed ID: 19265263
[TBL] [Abstract][Full Text] [Related]
2. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression].
Zhai XW; Wu Y; Gu XF; Lu FJ
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):62-5. PubMed ID: 14990112
[TBL] [Abstract][Full Text] [Related]
4. TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation.
Kato S; Takayama N; Takano H; Koretsune H; Koizumi C; Kunioka EI; Uchida S; Takahashi T; Yamamoto K
Eur J Pharmacol; 2018 Nov; 838():138-144. PubMed ID: 30179610
[TBL] [Abstract][Full Text] [Related]
5. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.
Clibon U; Bonewald L; Caro J; Roodman GD
Exp Hematol; 1990 Jun; 18(5):438-41. PubMed ID: 2338132
[TBL] [Abstract][Full Text] [Related]
7. Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor-independent mechanism.
Pascual M; Bohle B; Alonso S; Mayol X; Salvans S; Grande L; Pera M
J Surg Res; 2013 Jul; 183(1):270-7. PubMed ID: 23348072
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of erythropoietin-producing interstitial cells in the kidneys of ICR-derived glomerulonephritis (ICGN) mice.
Yamaguchi-Yamada M; Manabe N; Kiso M; Goto Y; Mori T; Sakata C; Anan S; Nagao M; Yamamoto Y; Ogura A
J Vet Med Sci; 2005 Sep; 67(9):891-9. PubMed ID: 16210801
[TBL] [Abstract][Full Text] [Related]
9. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
11. The implications of anemia in multiple myeloma.
Mittelman M
Clin Lymphoma; 2003 Aug; 4 Suppl 1():S23-9. PubMed ID: 14556675
[TBL] [Abstract][Full Text] [Related]
12. Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.
Alamo IG; Kannan KB; Smith MA; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2016 Oct; 81(4):705-12. PubMed ID: 27398985
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states.
Jelkmann WE; Fandrey J; Frede S; Pagel H
Ann N Y Acad Sci; 1994 Apr; 718():300-9; discussion 309-11. PubMed ID: 8185237
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma.
Fujimoto-Ouchi K; Tamura S; Mori K; Tanaka Y; Ishitsuka H
Int J Cancer; 1995 May; 61(4):522-8. PubMed ID: 7759158
[TBL] [Abstract][Full Text] [Related]
16. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response.
Anusornvongchai T; Nangaku M; Jao TM; Wu CH; Ishimoto Y; Maekawa H; Tanaka T; Shimizu A; Yamamoto M; Suzuki N; Sassa R; Inagi R
Kidney Int; 2018 Sep; 94(3):536-550. PubMed ID: 29887316
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
18. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
[TBL] [Abstract][Full Text] [Related]
19. Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells.
DiFalco MR; Congote LF
Cytokine; 2002 Apr; 18(1):51-60. PubMed ID: 12090760
[TBL] [Abstract][Full Text] [Related]
20. Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria.
Chang KH; Stevenson MM
Kidney Int; 2004 May; 65(5):1640-6. PubMed ID: 15086902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
